DCGI Grants Emergency Use Authorisation To Gennova's Omicron-Specific mRNA-Based Booster Vaccine
Swarajya StaffTuesday, June 20, 2023 03:01 PM IST
DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear EmergenciesSwarajya StaffTuesday, March 14, 2023 04:32 PM IST
'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political PressureSwarajya StaffThursday, November 17, 2022 02:09 PM IST
Govt Panel Recommends Emergency Use Authorisation For Single-Dose 'Sputnik Light' Covid VaccinePTISaturday, February 5, 2022 08:20 AM IST
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review ProposalsSwarajya StaffSaturday, January 15, 2022 03:23 PM IST
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTISaturday, October 30, 2021 10:03 AM IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Wednesday, October 13, 2021 01:00 PM IST
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On ChildrenIANSThursday, September 2, 2021 12:45 PM IST
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical TrialsSwarajya StaffWednesday, August 25, 2021 11:00 AM IST
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In IndiaSwarajya StaffFriday, August 20, 2021 01:06 PM IST
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's VelloreSwarajya StaffWednesday, August 11, 2021 11:45 AM IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffFriday, August 6, 2021 04:14 PM IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In IndiaSwarajya StaffFriday, August 6, 2021 09:29 AM IST
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In TrialsSwarajya StaffSaturday, July 31, 2021 10:41 AM IST
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: ReportSwarajya StaffWednesday, July 7, 2021 11:42 AM IST
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data FirstSwarajya StaffThursday, July 1, 2021 02:22 PM IST
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: ReportSwarajya StaffTuesday, June 29, 2021 02:43 PM IST
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 PatientsSwarajya StaffSaturday, June 12, 2021 02:03 PM IST
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In IndiaSwarajya StaffThursday, June 3, 2021 01:04 PM IST
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: ReportSwarajya StaffWednesday, June 2, 2021 12:01 PM IST